Abstract
A model is presented in which hospitals and patients exist at two points and in which a significant number of patients migrate from one point to the other because of perceived quality differences. Applying a market delineation test based on patient migration, such as the Elzinga-Hogarty test, this migration would lead to the conclusion that the relevant market for purposes of antitrust analysis includes both points. This conclusion is shown to be incorrect because a monopolist at the higher quality point generally would raise price significantly.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
